Reproterol
Back to searchMolecule Structure
Scientific Name
Reproterol
Description of the Drug
Reproterol is a short-acting β2 adrenoreceptor agonist used to treat various types of asthma including allergic asthma, non-allergic asthma, and exercise-induced asthma.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB12846
http://www.drugbank.ca/drugs/DB12846
Brand Name(s)
Not Available
Company Owner(s)
Not Available
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Beta-2 adrenergic receptor | SINGLE PROTEIN | AGONIST | CHEMBL210 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL83298 | |
| Human Metabolome Database | HMDB0257155 | |
| DrugBank | DB12846 | |
| PubChem: Thomson Pharma | 14878474 | |
| PubChem | 25654 | |
| Nikkaji | J12.331E | |
| EPA CompTox Dashboard | DTXSID8023553 | |
| DrugCentral | 2368 | |
| rxnorm | REPROTEROL | REPROTEROL HYDROCHLORIDE |
| ChEBI | 135612 |
